ZEVRA THERAPEUTICS, INC. GLOBAL HEADQUARTERS
101 Federal Street, 29th Floor
Boston, MA 02110
USA
+1.888.958.1253
FLORIDA CORPORATE OFFICE
1180 Celebration Boulevard, Suite 103
Celebration, FL 34747
USA
DENMARK CORPORATE OFFICE
Nordre Fasanvej 215
2000, Frederiksberg
Denmark
Zevra was previously known as KemPharm and was founded in 2006. In February 2023, the name was changed from KemPharm to Zevra Therapeutics.
The company is incorporated in Delaware.
Zevra has been public since 2015.
The Company’s stock is listed on the Nasdaq Stock Market LLC (Nasdaq Global Select) under the ticker symbol “ZVRA”.
Computershare
Computershare
www.computershare.com
By Regular Mail:
PO Box 43006
Providence, RI 02940-3006
UNITED STATES
By Overnight Delivery:
150 Royall Street
Suite 101
Canton, MA 02021
UNITED STATES
Telephone
Toll: +1-(781)-575-3100
Toll Free: 877-373-6374
To change the address on your shareholder account you must send both your new and old address to our transfer agent, Computershare.
By Regular Mail:
PO Box 43006
Providence, RI 02940-3006
UNITED STATES
By Overnight Delivery:
150 Royall Street
Suite 101
Canton, MA 02021
UNITED STATES
Telephone
Toll: +1-(781)-575-3100
Toll Free: 877-373-6374
www.computershare.com
Ernst & Young LLP
CUSIP number 488445107.
You may purchase Zevra stock through a registered stockbroker.
Zevra files periodic reports, including Annual Reports (Form 10-K), Quarterly Reports (Form 10-Q) and Current Reports (Form 8-K) with the Securities and Exchange Commission (SEC). These reports are available on our SEC Filings page, or at www.sec.gov.